Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31222826 | 0.91 | HMGCR (0.30) | — | |
| SCHEMBL10710668 | 0.86 | LMNA (0.35) | CA1LMNA | |
| SCHEMBL24764588 | 0.81 | — | — | |
| SCHEMBL1132741 | 0.78 | — | — | |
| SCHEMBL9547934 | 0.78 | GRIK1 (0.32) | LMNA | |
| SCHEMBL6218777 | 0.75 | — | — | |
| SCHEMBL2120316 | 0.75 | — | — | |
| SCHEMBL9547913 | 0.75 | — | — | |
| SCHEMBL2120332 | 0.73 | — | — | |
| SCHEMBL10610780 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1419815-B1 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | TAKASAGO PERFUMERY CO LTD (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-7078568-B2 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-18 | — | — | US | disclosed |
| US-6987202-B2 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-01-17 | — | — | US | disclosed |
| US-20050288531-A1 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | SHIMIZU HIDEO | 2005-12-29 | — | — | US | disclosed |
| EP-1419815-A1 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | Takasago International Corporation (JP) | 2004-05-19 | — | — | EP | disclosed |
| US-20040092388-A1 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288531-A1 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | PHOSPHO1, PRMT1, PRMT9 | CA1 1985/4885LMNA 4721/4885 |
| US-20040092388-A1 | Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes | PHOSPHO1, INPP5B, PRMT1 | CA1 1660/4885LMNA 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.